AR123050A1 - ANTI-Ab ANTIBODIES - Google Patents

ANTI-Ab ANTIBODIES

Info

Publication number
AR123050A1
AR123050A1 ARP210102073A ARP210102073A AR123050A1 AR 123050 A1 AR123050 A1 AR 123050A1 AR P210102073 A ARP210102073 A AR P210102073A AR P210102073 A ARP210102073 A AR P210102073A AR 123050 A1 AR123050 A1 AR 123050A1
Authority
AR
Argentina
Prior art keywords
antibodies
methods
bind
human
manufacture
Prior art date
Application number
ARP210102073A
Other languages
Spanish (es)
Inventor
Michael Skov
Tarlochan S Nijjar
Sridhar Govindarajan
Tom Purcell
Mark Welch
Frdrique Bard
Robin Barbour
Wagner Zago
Original Assignee
Othair Prothena Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Othair Prothena Ltd filed Critical Othair Prothena Ltd
Publication of AR123050A1 publication Critical patent/AR123050A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Se proporcionan anticuerpos que se unen al péptido b-amiloide humano, métodos para detectar, medir y tratar trastornos amiloidogénicos con dichos anticuerpos, composiciones farmacéuticas que comprenden los anticuerpos y métodos de elaboración.Antibodies that bind to human b-amyloid peptide, methods of detecting, measuring, and treating amyloidogenic disorders with such antibodies, pharmaceutical compositions comprising the antibodies, and methods of manufacture are provided.

ARP210102073A 2020-07-23 2021-07-23 ANTI-Ab ANTIBODIES AR123050A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202063055813P 2020-07-23 2020-07-23

Publications (1)

Publication Number Publication Date
AR123050A1 true AR123050A1 (en) 2022-10-26

Family

ID=83835148

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210102073A AR123050A1 (en) 2020-07-23 2021-07-23 ANTI-Ab ANTIBODIES

Country Status (1)

Country Link
AR (1) AR123050A1 (en)

Similar Documents

Publication Publication Date Title
ECSP18005520A (en) FACTOR XI ANTIBODIES AND METHODS OF USE
CL2018002694A1 (en) Molecules of antibodies that bind to lag-3 and uses thereof (divisional application 201602112)
CL2020001048A1 (en) Monoclonal antibodies against bcma. (divisional request 201800281)
CO2018005932A2 (en) Bispecific molecules that have immunoreactivity with pd-1 and ctla-4, and methods of use thereof
CL2018000829A1 (en) Human anti-cd19 antibodies with high affinity
CR20130621A (en) ANTI-ANGPTL3 ANTIBODIES AND USES OF THE SAME
ECSP20082648A (en) ANTI-SIRPA ANTIBODIES AND METHODS OF USING THEM
BR112021019334A2 (en) Heavy chain antibodies that bind to psma
CL2022000087A1 (en) Anti-tau antibody and use thereof
CO2020012360A2 (en) Multispecific antibodies and their use
CY1124153T1 (en) ANTIBODIES AND POLYPEPTIDES DIRECTED AGAINST CD127
MX2020009861A (en) Antibodies against mica and/or micb and uses thereof.
CL2021003343A1 (en) Multispecific heavy chain antibodies that bind to cd22 and cd3.
CL2020001334A1 (en) Antibodies that bind to the envelope protein of the Zika virus and their uses. (divisional request 201900999)
UY37598A (en) MIMETIC ANTIBODIES OF FGF21 AND USES OF THE SAME
AR115178A1 (en) ANTI-CD71 ACTIVABLE ANTIBODY AND DRUG CONJUGATES, AND THEIR METHODS OF USE
CO2021014260A2 (en) Solid forms of a glyt1 inhibitor
MX2020009130A (en) Therapeutic anti-spla2-gib antibodies and the uses thereof.
EA202190633A1 (en) DOSAGE FORMS FOR USE IN PEDIATRICS, METHODS OF OBTAINING AND APPLICATION
CL2023001064A1 (en) Anti-steap1 antigen binding protein
CL2023000216A1 (en) Anti-abeta antibodies
AR123050A1 (en) ANTI-Ab ANTIBODIES
CL2022002243A1 (en) Inhibitors and their uses
EA201992338A1 (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INFECTIOUS INFLAMMATORY DISEASES
CO2024000763A2 (en) Compositions and methods of anti-pacap antibodies